SPOKANE, Wash., Feb. 28 /PRNewswire/ -- HollisterStier Contract Manufacturing, a leading manufacturer of high quality sterile fill products for the global pharmaceutical and biopharmaceutical markets, recently signed a contract with ROXRO PHARMA Inc., a specialty pharma company focused on identifying, licensing, and developing compounds in specialized disease areas. HollisterStier will fill/finish under cGMP ROXRO’s first pain management candidate, ROX-888, through commercialization. HollisterStier and ROXRO PHARMA are purchasing new and specialized equipment to accommodate the project. ROXRO plans to file a New Drug Application for ROX-888 with the U.S. Food and Drug Administration after completion of its later stage Phase III trials.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060228/SFTU141LOGO )
“Our custom multidisciplinary team is excited to assist ROXRO in further developing their unique drug product and delivery system,” stated Anthony Bonanzino, Ph.D., president & CEO.
“This is further evidence of HollisterStier’s commitment to providing excellent customer service and fulfilling specific contract manufacturing goals for each of our clients.”
Roberto P. Rosenkranz, Ph.D., Chairman and CEO, ROXRO PHARMA, Inc., said, “ROXRO PHARMA is very pleased to be working with an established company of the caliber of HollisterStier as we advance our lead product to the manufacturing stage.”
About HollisterStier
HollisterStier is a customer centric group of professionals dedicated to the contract manufacture of high quality sterile injectables for the global pharmaceutical and biopharmaceutical market. Our multidisciplinary teams provide custom solutions to customer specific project goals from development through commercialization. Based in Spokane, Washington, the company is committed to meeting customer expectations in all aspects of our business from quality manufacturing to regulatory support. For further information, visit www.hollisterstier.com.
About ROXRO PHARMA, Inc.
ROXRO PHARMA Inc. is a specialty pharma company founded in 1999 and based in Menlo Park, California. The company develops compounds for the management of pain and intends to market these drug products.
Photo: http://www.newscom.com/cgi-bin/prnh/20060228/SFTU141LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comHollisterStier Contract Manufacturing
CONTACT: Janelle Jovick of HollisterStier Contract Manufacturing,+1-509-482-0586, or jjovick@hollister-stier.com
Web site: http://www.hollisterstier.com/
